The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 27, 2008

Filed:

Oct. 19, 2005
Applicants:

Zaid Jayyosi, Flemington, NJ (US);

Gerard M. Mcgeehan, Wilmington, DE (US);

Michael F. Kelley, West Chester, PA (US);

Richard F. Labaudiniere, Sherborn, MA (US);

Litao Zhang, Churchville, PA (US);

Robert D. Groneberg, Boulder, CO (US);

Daniel G. Mcgarry, Branchburg, NJ (US);

Thomas J. Caulfield, Lebanon, NJ (US);

Anne Minnich, Flemington, NJ (US);

Mark Bobko, Exton, PA (US);

Inventors:

Zaid Jayyosi, Flemington, NJ (US);

Gerard M. McGeehan, Wilmington, DE (US);

Michael F. Kelley, West Chester, PA (US);

Richard F. Labaudiniere, Sherborn, MA (US);

Litao Zhang, Churchville, PA (US);

Robert D. Groneberg, Boulder, CO (US);

Daniel G. McGarry, Branchburg, NJ (US);

Thomas J. Caulfield, Lebanon, NJ (US);

Anne Minnich, Flemington, NJ (US);

Mark Bobko, Exton, PA (US);

Assignee:

Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 215/14 (2005.12); C07D 263/32 (2005.12); A61K 31/421 (2005.12); A61K 31/47 (2005.12); A61P 3/04 (2005.12); A61P 3/10 (2005.12); A61P 9/02 (2005.12);
U.S. Cl.
CPC ...
Abstract

The use of diaryl acid derivatives of formula (I)or pharmaceutically acceptable salts, N-oxides, hydrates or solvates thereof, wherein the variables shown are defined in the disclosure, and their pharmaceutical compositions as PPAR ligand receptor binders. The PPAR ligand receptor binders of this invention are useful as agonists or antagonists of the PPAR receptor.


Find Patent Forward Citations

Loading…